JP2021529168A5 - - Google Patents

Info

Publication number
JP2021529168A5
JP2021529168A5 JP2020570716A JP2020570716A JP2021529168A5 JP 2021529168 A5 JP2021529168 A5 JP 2021529168A5 JP 2020570716 A JP2020570716 A JP 2020570716A JP 2020570716 A JP2020570716 A JP 2020570716A JP 2021529168 A5 JP2021529168 A5 JP 2021529168A5
Authority
JP
Japan
Prior art keywords
groups
optionally substituted
disease
alkyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020570716A
Other languages
English (en)
Japanese (ja)
Other versions
JP7510358B2 (ja
JP2021529168A (ja
Filing date
Publication date
Priority claimed from GBGB1810668.2A external-priority patent/GB201810668D0/en
Application filed filed Critical
Publication of JP2021529168A publication Critical patent/JP2021529168A/ja
Publication of JP2021529168A5 publication Critical patent/JP2021529168A5/ja
Application granted granted Critical
Publication of JP7510358B2 publication Critical patent/JP7510358B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020570716A 2018-06-28 2019-06-28 Trk受容体の調節剤としての4-置換フェニル-1,3,5-トリアジン誘導体 Active JP7510358B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1810668.2A GB201810668D0 (en) 2018-06-28 2018-06-28 New compounds
GB1810668.2 2018-06-28
PCT/GB2019/051853 WO2020002950A1 (en) 2018-06-28 2019-06-28 4-substituted phenyl-1,3,5-triazine derivatives as modulators of trk receptors

Publications (3)

Publication Number Publication Date
JP2021529168A JP2021529168A (ja) 2021-10-28
JP2021529168A5 true JP2021529168A5 (enExample) 2022-06-30
JP7510358B2 JP7510358B2 (ja) 2024-07-03

Family

ID=63143731

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020570716A Active JP7510358B2 (ja) 2018-06-28 2019-06-28 Trk受容体の調節剤としての4-置換フェニル-1,3,5-トリアジン誘導体

Country Status (10)

Country Link
US (1) US11840524B2 (enExample)
EP (1) EP3814335B1 (enExample)
JP (1) JP7510358B2 (enExample)
KR (1) KR20210024531A (enExample)
CN (1) CN112513032B (enExample)
BR (1) BR112020026619A2 (enExample)
CA (1) CA3104237A1 (enExample)
ES (1) ES2935183T3 (enExample)
GB (1) GB201810668D0 (enExample)
WO (1) WO2020002950A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020008816A (es) 2018-02-26 2020-09-28 AlzeCure Pharma AB Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas.
GB201912404D0 (en) * 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds
CA3180846A1 (en) * 2020-06-03 2021-12-09 Dana-Farber Cancer Institute, Inc. Inhibitors of transcriptional enhanced associate domain (tead) and uses thereof
WO2025232990A1 (en) 2024-05-09 2025-11-13 AlzeCure Pharma AB Triazinone derivatives for use in the treatment of inflammation

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2246109A1 (de) 1972-09-20 1974-03-28 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazinderivate, ein verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
DE2313721A1 (de) 1973-03-20 1974-10-03 Bayer Ag Neue 1-phenylsubstituierte 1,3,5triazine, verfahren zu ihrer herstellung, sowie ihre verwendung als arzneimittel
DE2413722C3 (de) 1974-03-21 1982-04-08 Bayer Ag, 5090 Leverkusen Neue 1-(4-Phenoxy-phenyl)-1,3,5-triazin-Derivate, ein Verfahren zu ihrer Herstellung sowie ihre Anwendung als Arzneimittel
DE2718799A1 (de) 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3271848D1 (en) 1981-12-03 1986-07-31 Basf Ag 1,3,5-triazinones, process for their preparation and their use in combating undesired plant growth
DE3314739A1 (de) 1983-04-23 1984-10-25 Bayer Ag, 5090 Leverkusen 1-(4-(4-(fluoralkylmethylthio- oder -sulfinyl- oder -sulfonyl-)phenoxy) phenyl)-1,3,5-triazin-2,4,6(1h,3h,5h)-trione, verfahren zu ihrer herstellung und ihre verwendung als coccidiosemittel
DE3408768A1 (de) 1984-03-09 1985-09-12 Bayer Ag, 5090 Leverkusen Immunstimulierende mittel
DE3516632A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 1,3,5-triazintrionen
DE3516631A1 (de) 1985-05-09 1986-11-13 Bayer Ag, 5090 Leverkusen Verfahren zur herstellung von 3-methyl-1,3,5-triazintrionen
DE3703105A1 (de) 1987-02-03 1988-08-11 Bayer Ag Mittel gegen protozoen bei insekten
DE3810080A1 (de) 1988-03-25 1989-10-05 Bayer Ag Trisubstituierte 1,3,5-triazin-2,4,6-trione
DE3814323A1 (de) 1988-04-28 1989-11-09 Hoechst Ag Wasserloesliche zubereitungen von coccidiostatica
US4933341A (en) 1988-10-08 1990-06-12 Bayer Aktiengesellschaft Substituted 1,3,5-triazinetriones, for use against parasitic protozoa
DE4000624A1 (de) 1990-01-11 1991-07-18 Bayer Ag Fungizide verwendung von trisubstituierten 1,3,5-triazin-2,4,6-trionen, neue trisubstituierte 1,3,5-triazin-2,4,6-trione und verfahren zu ihrer herstellung
DE4329096A1 (de) 1993-08-30 1995-03-02 Bayer Ag Heterocyclylbenzoheterocyclen
US5604180A (en) 1995-06-02 1997-02-18 Crews, Jr.; Alvin D. 3-(3-aryloxyphenyl)-1 (substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
US5519133A (en) 1995-06-02 1996-05-21 American Cyanamid Co. 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
CZ146296A3 (en) 1995-06-02 1997-04-16 American Cyanamid Co 3-(3-aryloxyphenyl)-1-(substituted methyl)-s-triazine-2,4,6-oxo or thiotriones, process of their preparation and herbicidal agents
US5726126A (en) * 1995-06-02 1998-03-10 American Cyanamid Company 1-(3-heterocyclyphenyl)-S-triazine-2,6,6-oxo or thiotrione herbicidal agents
US5679791A (en) 1996-07-25 1997-10-21 American Cyanamid Company 1-(3-heterocyclylphenyl)-s-triazine-2,4,6-oxo or thiotrione herbicidal agents
AU766542B2 (en) 1998-10-08 2003-10-16 New Ace Research Company Novel compositions and methods for prevention and treatment of protozoal disease
CN1331595A (zh) 1998-12-22 2002-01-16 美国拜尔公司 肉孢子虫属、新孢子虫属(Neospora)和弓形虫属引起的疾病治疗用三嗪酮化合物
DE19937500A1 (de) 1999-08-09 2001-02-15 Bayer Ag Substituierte Heterocyclylbenzofurane
DE19958388A1 (de) 1999-12-03 2001-06-07 Bayer Ag Triazinonverbindungen zur Behandlung von durch den Befall mit parasitischen Protozoen bedingten Krankheiten
US6444615B1 (en) 2000-04-18 2002-09-03 Dow Agrosciences Llc Herbicidal imidazolidinetrione and thioxo-imidazolidinediones
DE10034800A1 (de) 2000-07-18 2002-01-31 Bayer Ag Substituierte Benzostickstoffheterocyclen
DE10040110A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
US6861523B2 (en) 2002-02-08 2005-03-01 Torrey Pines Institute For Molecular Studies 1,3,5- trisubstituted-1,3,5-triazine-2,4,6-trione compounds and libraries
WO2003101980A1 (en) 2002-05-30 2003-12-11 Solvay Pharmaceuticals B.V. 1,3,5-triazine derivatives as ligands for human adenosine-a3 receptors
WO2004007499A1 (en) 2002-07-15 2004-01-22 Janssen Pharmaceutica N.V. 3-furanyl analogs of toxoflavine as kinase inhibitors
DE102006038292A1 (de) 2006-08-16 2008-02-21 Bayer Healthcare Ag Transdermale Anwendung von Triazinen zur Bekämpfung von Coccidien-Infektionen
WO2008148008A1 (en) * 2007-05-23 2008-12-04 Emory University High throughput bioassay for identifying selective trka receptor agonists, and gambogic amide, a selective trka agonist with neuroprotective activity
US20120004310A1 (en) 2010-05-28 2012-01-05 Longo Frank M Non-peptide bdnf neurotrophin mimetics
CN105209427B (zh) * 2013-03-15 2018-05-25 特罗菲克斯制药股份有限公司 非肽bdnf神经营养蛋白模拟物
KR101861942B1 (ko) 2014-01-20 2018-06-29 에프. 호프만-라 로슈 아게 신경 발생을 자극할 수 있는 n-페닐-락탐 유도체 및 이의 신경 장애 치료에서의 용도
EP3229611B1 (en) 2014-12-10 2025-03-26 Mars, Incorporated Compounds that modulate fatty acid receptor activity and pet food products containing the same
JP2020502225A (ja) 2016-12-21 2020-01-23 アルゼキュア ファーマ アーべー トリアジントリオン誘導体、ならびにニューロトロフィン受容体および受容体型チロシンキナーゼのモジュレーターとしてのその使用。
MX2020008816A (es) 2018-02-26 2020-09-28 AlzeCure Pharma AB Derivados de triazina para el tratamiento de enfermedades relacionadas con neurotrofinas.
GB201810669D0 (en) 2018-06-28 2018-08-15 Stiftelsen Alzecure New compounds
GB201912404D0 (en) 2019-08-29 2019-10-16 AlzeCure Pharma AB New compounds

Similar Documents

Publication Publication Date Title
JP2021529168A5 (enExample)
JP6847093B2 (ja) ムスカリン様アゴニスト
US7999006B2 (en) Methods of using MEK inhibitors
AU2026200636A1 (en) Substituted cycloalkyls as modulators of the integrated stress pathway
JP2020530446A5 (enExample)
JP2023514872A5 (enExample)
JP2021006571A (ja) ムスカリンm1受容体アゴニストとしての二環式アザ化合物
JP2019515931A5 (enExample)
EP1809601B1 (en) Compounds for alzheimer's disease
CA3180819A1 (en) Substituted aminothiazoles as dgkzeta inhibitors for immune activation
JP2021517893A5 (enExample)
JP2010518026A5 (enExample)
JP5667684B2 (ja) 関節炎の治療方法
JP2024540445A5 (enExample)
US9034871B2 (en) Compounds for Alzheimer's disease
JP2021514963A5 (enExample)
JP7362600B2 (ja) Rip1キナーゼ阻害剤として使用するための二環式化合物
JP2022508953A (ja) Hbvの処置のための5員のヘテロアリールカルボキサミド化合物
JP2016529251A (ja) Alx受容体アゴニストとしてのベンゾイミダゾリル−メチル尿素誘導体
IL276624B1 (en) Triazine derivatives for the treatment of neurotrophin-related diseases
AU2021268223B2 (en) Compound having KDM5 inhibitory activity and pharmaceutical use thereof
TW201920153A (zh) 具有環狀構造的化合物
HUP0200441A2 (hu) Tetrahidropiránszármazékok és terápiás szerként való alkalmazásuk és eljárás a vegyületek előállítására
US20210317092A1 (en) Tetrazole containing compounds
JP2023548169A (ja) 統合的ストレス経路の調節剤